A 10-week Multicenter,Forced-titration Study Using 24-hr ABPM to Evaluate the Efficacy of Valsartan/Hydrochlorothiazide (HCTZ) Treatment Regimen vs Conventional Treatment Regimen With Amlodipine and Hydrochlorothiazide (HCTZ) in Patients With Stage 2 Hypertension.

Trial Profile

A 10-week Multicenter,Forced-titration Study Using 24-hr ABPM to Evaluate the Efficacy of Valsartan/Hydrochlorothiazide (HCTZ) Treatment Regimen vs Conventional Treatment Regimen With Amlodipine and Hydrochlorothiazide (HCTZ) in Patients With Stage 2 Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Amlodipine; Hydrochlorothiazide; Valsartan; Valsartan/hydrochlorothiazide
  • Indications Essential hypertension; Hypertension
  • Focus Therapeutic Use
  • Acronyms EVALUATE
  • Sponsors Novartis
  • Most Recent Events

    • 13 Jun 2009 Results were presented at the 19th European Meeting on Hypertension.
    • 03 Jun 2009 Results published in Blood Pressure Monitoring 14: 112-120, No. 3, June 2009.
    • 19 Jun 2008 Primary efficacy results presented at ESH-ISH in June 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top